EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells
- 1 September 1993
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 46 (3), 365-371
- https://doi.org/10.1016/0960-0760(93)90226-m
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Vitamin D analogs with low affinity for the vitamin D binding protein: Enhanced in vitro and decreased in vivo activityJournal of Bone and Mineral Research, 1991
- Perspectives: The genomic mechanism of action of 1,25-dihydroxyvitamin D3Journal of Bone and Mineral Research, 1991
- 20-EPI-vitamin D3 analogues: A novel class of potent regulators of cell growth and immune responsesBiochemical Pharmacology, 1991
- Vitamin D3 Receptors: Structure and Function in TranscriptionAnnual Review of Nutrition, 1991
- In vitro study of effects of 1,25 dihydroxyvitamin D3 on the morphology of human breast cancer cell line BT.20Differentiation, 1989
- POSSIBLE ROLE FOR VITAMIN D IN CONTROLLING BREAST CANCER CELL PROLIFERATIONThe Lancet, 1989
- The vitamin d receptor: A primitive steroid receptor related to thyroid hormone receptorJournal of Steroid Biochemistry, 1988
- Vitamin D-endocrine system.JCI Insight, 1985
- 1,25-DIHYDROXYVITAMIN D3AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTUREEndocrinology, 1981
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979